13F 中

ENGN enGene Therapeutics Inc.

2026Q1 · CUSIP 29286M105 · Sector: Healthcare & Biotech

⚪ Neutral · No signal
Holders
58
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
24
Δ whales
-1
Inst. holding value
$380M
New positions
12
Closed positions
11
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2024Q1: Δ+20 · h=32 2024Q2: Δ-1 · h=31 2024Q3: Δ+0 · h=31 2024Q4: Δ+4 · h=35 2025Q1: Δ-3 · h=32 2025Q2: Δ+6 · h=38 2025Q3: Δ+0 · h=38 2025Q4: Δ+19 · h=57 2026Q1: Δ+1 · h=58 2024Q1: holders=32 2024Q2: holders=31 2024Q3: holders=31 2024Q4: holders=35 2025Q1: holders=32 2025Q2: holders=38 2025Q3: holders=38 2025Q4: holders=57 2026Q1: holders=58 -20 -10 +0 +10 +20 274461 24Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q1 Top 15% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →